Nakamura K, Endo F, Ueno T, Awata H, Tanoue A, Matsuda I
Department of Pediatrics, Kumamoto University School of Medicine.
J Biol Chem. 1995 Mar 31;270(13):7656-60. doi: 10.1074/jbc.270.13.7656.
Immortalized hepatic cell lines obtained from laboratory animals or patients with defects in copper metabolism in the liver provide new approaches to examine related metabolism and toxicity. We established a series of hepatic cell lines from the liver of Long-Evans Cinnamon (LEC) rats, using recombinant adenovirus which expresses SV40 large T. Cells from the LEC rats were cultured and accumulated larger amounts of copper than did control cells, when the concentrations of copper in the culture medium exceeded 5 microM. The secretion of ceruloplasmin (CP) from the cultured cells was not reduced in hepatocytes from LEC cells, as compared with the control cells. As accumulation of copper did not affect CP secretion, CP production was not likely to be affected by the accumulation of copper in LEC rat hepatocytes. The production of holo-CP was further investigated by transfection of human CP cDNA and detection of human holo-CP by immunological procedures and use of a monoclonal antibody (mAb CP60) which recognizes human holo-CP but not human apo-CP and rat CP. Hepatocytes from the LEC rats processed and secreted holo-CP into the medium, even with excess copper present in the medium. These observations suggest that the genetic defect in LEC rats did not alter biosynthetic and secretory pathways of CP and that the intracellular copper concentration did not regulate the synthesis and processing of CP in the cultured hepatocytes. Low ceruloplasmin levels are observed in most, but not all, patients with Wilson disease, as well as in LEC rats. Our results do suggest that the copper transporting ATPase encoded in the Wilson disease gene is not a integral part of the biochemical mechanism of copper incorporation into apoprotein. The cell lines and immunological procedures we used are expected to add to information on biologically important process related to copper metabolism and to CP biosynthesis.
从实验动物或肝脏铜代谢存在缺陷的患者获得的永生化肝细胞系为研究相关代谢和毒性提供了新方法。我们使用表达SV40大T抗原的重组腺病毒,从Long-Evans肉桂色(LEC)大鼠的肝脏建立了一系列肝细胞系。当培养基中铜浓度超过5微摩尔时,LEC大鼠的细胞进行培养并积累了比对照细胞更多的铜。与对照细胞相比,LEC细胞的肝细胞中培养细胞分泌的铜蓝蛋白(CP)并未减少。由于铜的积累并未影响CP的分泌,因此CP的产生不太可能受到LEC大鼠肝细胞中铜积累的影响。通过转染人CP cDNA并通过免疫程序和使用识别人类全铜蓝蛋白但不识别人类脱辅基铜蓝蛋白和大鼠CP的单克隆抗体(mAb CP60)检测人类全铜蓝蛋白,进一步研究了全铜蓝蛋白的产生。即使培养基中存在过量的铜,LEC大鼠的肝细胞仍能加工并将全铜蓝蛋白分泌到培养基中。这些观察结果表明,LEC大鼠的遗传缺陷并未改变CP的生物合成和分泌途径,并且细胞内铜浓度并未调节培养肝细胞中CP的合成和加工。在大多数但并非所有威尔逊病患者以及LEC大鼠中都观察到铜蓝蛋白水平较低。我们的结果确实表明,威尔逊病基因中编码的铜转运ATP酶不是铜掺入脱辅基蛋白生化机制的组成部分。我们使用的细胞系和免疫程序有望增加与铜代谢和CP生物合成相关的生物学重要过程的信息。